Tata Healthcare Likely To Launch Moderna's COVID-19 Vaccine In India

Tata Medical and Diagnostics Ltd are likely to launch Moderna's COVID-19 vaccine in India as it has started exploratory talks with US’ Moderna Inc. To carry out the clinical trials, the Tata group's healthcare venture might collaborate with the Council of Scientific and Industrial Research. Varying from Pfizer’s vaccine, Moderna can be stored at normal fridge temperature, making it more favourable to be adopted by underdeveloped countries having limited cold chains.